We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
HWH | HWH International Inc | 2.09 | 0.81 | 63.28% | 2,474,432 |
PEGY | Pineapple Energy Inc | 0.0629 | 0.0171 | 37.34% | 23,129,514 |
IBRX | ImmunityBio Inc | 6.25 | 1.31 | 26.52% | 1,221,157 |
NUWE | Newellis Inc | 0.4179 | 0.0839 | 25.12% | 2,624,944 |
EVGN | Evogene Ltd | 0.78 | 0.1299 | 19.98% | 1,152 |
BFI | BurgerFi International Inc | 0.477 | 0.0782 | 19.61% | 2,564 |
HIBB | Hibbett Inc | 86.00 | 13.51 | 18.64% | 18,782 |
CHNR | China Natural Resources Inc | 1.18 | 0.18 | 18.00% | 470,548 |
BOXL | Boxlight Corporation | 0.61 | 0.0899 | 17.29% | 94 |
AGBA | AGBA Group Holding Ltd | 2.90 | 0.40 | 16.00% | 2,152,123 |
NYMT | New York Mortgage Trust Inc | 8.16 | 1.10 | 15.58% | 1 |
ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has approved ANKTIVA (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.
Hibbett, Inc. (“Hibbett”) (Nasdaq:HIBB), an athletic-inspired fashion retailer, today announced a definitive agreement in which JD Sports Fashion plc (“JD Sports”) (LSE:JD) will acquire all outstanding shares of Hibbett for $87.50 per share in cash, representing an aggregate enterprise value of approximately $1.1 billion.
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that an abstract featuring new preclinical data highlighting ADI-270, an armored allogeneic “off-the-shelf” gamma delta CAR (chimeric antigen receptor) T cell therapy candidate targeting CD70 positive cancers, has been selected for an oral presentation at the ASGCT 27th Annual Meeting taking place from May 7-11, 2024, in Baltimore, MD. The oral presentation will take place on May 10, 2024 in the Targeted Gene and Cell Therapy session, co-chaired by Adicet Bio’s Chief Scientific Officer, ...
FY 2023: 5-year-record Revenues $26.6 million; EBITDA Growth of 2350%Q4 2023: Revenues $5.7 million; EBITDA $1.1 million; Non-GAAP EPS of $0.15 TEL AVIV, Israel , April 22, 2024 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, today reported results for the twelve months and fourth quarter, ended December 31, 2023.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 66,296.05 | -561.90 | -0.84% | 1.3T | 3,490,758,953 |
ETH | Ethereum | 3,185.96 | -16.10 | -0.50% | 382.32B | 1,585,224,858 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 97.84B | 401,278,863 |
BNB | Binance Coin | 610.07 | 4.97 | 0.82% | 96.6B | 290,890,361 |
SOL | Solana | 155.35 | -1.66 | -1.06% | 68.41B | 1,058,557,339 |
STETH | stETH | 3,179.20 | -21.26 | -0.66% | 31.21B | 3,187,444 |
XRP | Ripple | 0.5459 | -0.0107 | -1.92% | 29.79B | 431,307,618 |
USDC | USD Coin | 0.9998 | -0.0002 | -0.02% | 28.07B | 1,068,264,177 |
DOGE | Dogecoin | 0.15904 | -0.00219 | -1.36% | 22.74B | 378,617,130 |
TONCOIN | Wrapped TON Coin | 5.71 | -0.201268 | -3.40% | 19.82B | 129,435,595 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions